In March 2025, Juventas Cell Therapy Ltd. conducted a phase Ib/II trial to evaluate the safety and efficacy of CNCT19 ...

For some leukemia patients, each hour of delayed care can be the difference between life and death. JHU's Eugene Shenderov is ...

Two scientists describe how an acute myeloid leukemia diagnosis underscores the need for continued federal support for research and access to care.

BANTING: A young boy who is battling acute lymphoblastic leukemia (blood cancer) fulfilled his dream of experiencing military ...

The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the ...

Akriti Jain, MD, discussed how emerging data on non-ABL1 mutations is reshaping chronic myeloid leukemia management.

Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that ...

This study reveals that the expression of the Src-family kinase (SFK), FGR, alone can induce cell differentiation similar to RA."BUFFALO, NY – March ...

Company advancing off-the-shelf CAR-NK cell therapy programs for oncology indications with lead candidate, SENTI-202, in clinical development for ...

A Vancouver Island family is facing an unimaginable challenge after their five-year-old son was diagnosed with a rare form of ...

NEW YORK – Invivoscribe announced Thursday that its test for FLT3 mutations in patients with leukemia has achieved regulatory compliance in the UK and Switzerland.